Some people do not pay attention to gynecological examination and cervical disease screening, resulting in the detection of cervical cancer in the middle and late stages and delayed treatment; 2. Some people are overly nervous and have repeated examinations and even over-treatment in multiple hospitals in a short period of time; 3. Most people cannot get regular and standard cervical lesion treatment services. The common clinical cervical diseases are: 1. Chronic cervicitis includes the more familiar pathological types such as cervical erosion, cervical hypertrophy and polyps. The term “cervical erosion” is one of the most commonly used in clinical practice and has been the target of gynecologists’ active examination and diagnosis and even treatment for many years, with the progress of medicine and the deepening of the understanding of the disease, the so-called “cervical erosion” was a misnomer before. It is not a true erosion of the cervix, but is related to age, estrogen levels, birth injuries and some physiological states. This statement was abandoned years ago abroad and is gradually being changed in the domestic obstetrics and gynecology community. So for clinicians to diagnose cervical erosion Ⅰ, Ⅱ, Ⅲ do not worry too much, need to further check whether it is a normal physiological state or the existence of cervical precancer, high-risk factors, which is the main purpose of cervical lesion screening and diagnosis; 2, cervical precancerous lesions, namely cervical intraepithelial neoplasia (referred to as CIN), can be divided into CIN grade I, grade II, grade III (including cervical carcinoma in situ), not all Not all CIN will definitely progress to cervical cancer. Long-term follow-up studies have found that the natural course of CIN may have three outcomes, namely lesion regression, maintenance, and lesion progression. Approximately one-third of untreated high-grade lesions can progress to cancer within 10 years, while approximately 70% of low-grade lesions will reverse spontaneously or remain unchanged. Following WHO guidelines for clinical management of cervical lesions with liquid-based cytology, satisfactory colposcopy, high-risk HPV virus testing, and necessary biopsy pathology diagnosis can accurately diagnose CIN and provide an appropriate treatment basis, minimizing lesion underdiagnosis and overtreatment.3. Early to mid-stage cervical invasive carcinoma (before stage IIa) is treated by standardized radical cervical cervical cancer surgery: i.e. extensive hysterectomy and pelvic lymph node dissection, supplemented by 3D conformal radiotherapy and chemotherapy for those with high-risk factors, can achieve the goal of cure. Intermediate and advanced cervical cancer, especially locally advanced cancer, can be treated with surgery or radiation therapy after down-staging by preoperative chemotherapy.